生物学的特異性mAbSの世界市場2032年までの機会と戦略Including1) タイプ別タイプ別:Catumaxomab (Removab); Blinatumomab; Emicizumab; Amivantamab; Faricimab; Teclistamab2)適応症別:がん; 血友病A; 眼科3)エンドユース別:病院3)2032年までの世界市場機会・戦略癌、血友病A、眼科3) エンドユース別:病院、研究機関Covering:F.ホフマン・ラ・ロシュ;アムジェン;ジョンソン・エンド・ジョンソンBiSpecific mAbS Global Market Opportunities And Strategies To 2032Including: 1) By Type: Catumaxomab (Removab); Blinatumomab; Emicizumab; Amivantamab; Faricimab; Teclistamab2) By Indication: Cancer; Hemophilia A; Ophthalmic3) By End Use: Hospitals; Research InstitutesCovering: F. Hoffmann-La Roche AG; Amgen Inc; Johnson & Johnson この調査レポートは、2032年までの二特異性mAbSの世界市場のビジネスチャンスと戦略について調査・分析した結果を掲載したビジネス調査報告書です。 購入の理由 - 12地域をカバーするこの市場に関する最も包... もっと見る
サマリーこの調査レポートは、2032年までの二特異性mAbSの世界市場のビジネスチャンスと戦略について調査・分析した結果を掲載したビジネス調査報告書です。購入の理由 - 12地域をカバーするこの市場に関する最も包括的なレポートにより、真にグローバルな視点を得ることができる。 - 市場がコロナウイルスからどのような影響を受けているのか、また、ウイルスの影響が和らぐにつれて市場がどのように立ち上がり、成長していくのかを理解することができます。 - 現地のデータと分析に基づき、地域別および国別の戦略を策定します。 - 投資の対象となる成長セグメントを特定する。 - 予測データと市場を形成するドライバーとトレンドを活用し、競合他社を凌駕する。 - 最新の市場調査結果に基づいて顧客を理解する。 - 主要な競合他社とのパフォーマンスの比較 - 主要データセット間の関係を活用し、優れた戦略を立てる。 - 信頼性の高い高品質なデータと分析により、社内外のプレゼンテーションをサポートします。 説明 二重特異性mAbSの最大かつ急成長市場はどこか?経済全体、人口動態、他の類似市場との関連は?今後の市場を形成する力は何か?ビジネスリサーチ社の二重特異性mAbS市場に関する調査レポート「二重特異性mAbSの世界市場」は、これらすべての疑問やその他多くの疑問にお答えします。 当レポートでは、市場の特徴、規模および成長、セグメンテーション、地域別および国別内訳、競合情勢、市場シェア、市場の動向と戦略について解説しています。市場の歴史をたどり、地域別の市場成長を予測しています。また、二重特異性mAbS市場全体の中で同市場を位置づけ、他市場との比較も行っています。 本レポートは以下の章をカバーしています。 - 序論と市場の特徴 市場細分化、定義、二重特異性mAbs市場についての簡単な紹介。 - 主要動向 世界の二重特異性mAbs市場を形成している主要トレンドをハイライトしています。また、同市場における今後の展開についても取り上げます。 - 世界の市場規模と成長 世界の過去(2017年~2022年)および予測(2022年~2027年)、(2027年~2032年)の市場価値、過去および予測期間における市場の成長を支え、制御する促進因子および阻害因子を紹介します。 - 地域別分析 地域別の過去(2017-2022年)および予測(2022-2027年)、(2027-2032年)市場価値と成長率、市場シェア比較。 - 市場セグメンテーション 市場におけるタイプ別、適応症別、エンドユース別の市場価値(2017-2032年)と各セグメントの分析を収録。 - 地域別市場規模と成長 地域別の市場規模(2022年)、過去(2017年~2022年)および予測(2022年~2027年)、(2027年~2032年)の市場価値、地域内各国の成長率および市場シェア比較を掲載。本レポートには、アジア太平洋、西欧、東欧、北米、南米、中東、アフリカの全地域と各地域内の主要国に関する情報が含まれています。 - 競争環境 市場の競争状況、推定市場占有率、主要企業の会社プロファイルの詳細を掲載しています。 - 主要なM&A 本レポートでカバーしている市場における最近のM&Aに関する情報を掲載しています。近年の市場を形成したM&Aに関する主要な財務情報を掲載しています。 - 市場機会と戦略 調査結果に基づく市場機会と戦略を掲載しています。このセクションでは、国やセグメントごとの成長機会や、それらの市場で取るべき戦略に関する情報も提供します。今後5年間に競合他社が大きなビジネスを獲得できる可能性のある市場について理解することができる。 - 結論と提言 本セクションには、調査結果に基づく結論と提言が含まれる。また、製品・サービスの提供、地理的拡大、マーケティング戦略、ターゲットグループなどの観点から、二重特異性mAbSプロバイダーに対する提言も行う。 - 付録 このセクションには、本レポートで使用したNAICSコード、略語、通貨コードの詳細が含まれています。 スコープ 対象市場 1) タイプ別カツマキソマブ(リムーブマブ™);ブリナツモマブ;エミシズマブ;アミバンタマブ;ファリシマブ;テクリスタマブ 2)適応症別癌、血友病A、眼科 3) エンドユーザー別:病院、研究機関、その他 言及された企業F.ホフマン・ラ・ロシュ;アムジェン;ジョンソン・エンド・ジョンソン 国別中国、オーストラリア、インド、インドネシア、日本、韓国、米国、ブラジル、フランス、ドイツ、英国、ロシア 地域アジア太平洋; 西ヨーロッパ; 東ヨーロッパ; 北アメリカ; 南アメリカ; 中東; アフリカ 時系列:過去5年間および過去10年間の予測。 データデータ:市場規模と成長率の関連市場に対する比率、GDP比率、一人当たり支出、二種特異的mAbS指標の比較。 データ区分:国・地域の過去および予測データ、競合他社の市場シェア、市場セグメント。 ソーシングと参照:本レポート中のデータおよび分析は、エンドノートを使用しています。 当レポートでは、二重特異性mAbs市場について記載・解説し、2017-2022年を過去期間、2022-2027年を予測期間とし、2027-2032年のさらなる予測を加えています。本レポートでは、各地域および各地域内の主要経済圏の市場を評価しています。 世界の二重特異性mAbs市場は、2017年以降年平均成長率(CAGR)69.9%で成長し、2022年には約44億6,240万ドルに達した。市場は2022年の44億6,240万ドルから2027年には118億1,100万ドルに21.5%の成長率で拡大すると予想される。その後、2027年からCAGR13.5%で成長し、2032年には222億5,590万ドルに達すると予想される。 歴史的な期間の成長は、医療費の増加、資金調達の増加、政府の取り組みによるものである。 今後は、癌の有病率の増加、高齢化人口の増加、慢性疾患の有病率の増加が市場成長の原動力となるだろう。将来の二重特異性mAbs市場の成長を阻害する要因としては、ロシア・ウクライナ戦争や、癌に対する様々な代替治療法の利用可能性などが挙げられる。 二重特異性mAbs市場はタイプ別にブリナツモマブ、エミシズマブ、アミバンタマブ・ファリシマブ、テクリスタマブに区分される。エミシズマブ市場は、2022年に全体の86.6%を占める二重特異性mAbs市場の最大セグメントである。今後、アミバンタマブ市場は、タイプ別に区分された二重特異性mAbs市場において最も急成長するセグメントとなり、2022〜2027年のCAGRは44.8%となる見込みである。 二重特異性mAbs市場は適応症別にがん、血友病A、眼科に区分される。血友病A市場は、2022年に全体の86.6%を占める適応症別二特異性mAbs市場の最大セグメントであった。今後、眼科市場は適応症別二特異性mAbs市場において最も急成長するセグメントであり、2022〜2027年のCAGRは46.5%と予想される。 二重特異性mAbs市場は、最終用途別に病院、研究機関、その他のエンドユーザーに区分される。病院市場は、エンドユーザー別にセグメント化された二重特異性mAbs市場の最大セグメントで、2022年には全体の65.5%を占めた。今後、病院市場はエンドユーザー別に区分された二重特異性mAbs市場で最も急成長するセグメントとなり、2022〜2027年のCAGRは21.9%になると予想される。 二重特異性mAbs市場で最大の地域は北米で、2022年には全体の62.6%を占めた。次いで西欧、アジア太平洋、その他の地域と続く。今後、二重特異性mAbs市場で最も急速に成長する地域は西欧とアジア太平洋で、それぞれCAGR17.2%と11.5%で成長する。これに続くのは中東と南米で、それぞれCAGR4.2%と2.0%の成長が見込まれる。 世界の二重特異性mAbs市場は非常に集中しており、少数の大手企業が市場の大半を占めている。2021年には競合3社で市場の100%を占めている。最近の技術革新が各社の市場プレゼンス強化に貢献している。F.ホフマン・ラ・ロシュAGが市場シェア85.74%で最大手、アムジェンIncが13.45%、ジョンソン・エンド・ジョンソンが0.81%である。 二重特異性mAbs市場をタイプ別にセグメント化すると、エミシズマブ(emicizumab)セグメントに大きなビジネスチャンスがあり、2027年までに世界全体の年間売上高が58億6,830万ドルに達すると予想される。適応症別では、2027年までに58億6830万ドルの世界年間売上高を獲得する血友病Aセグメントで最大のビジネスチャンスが生まれるだろう。エンドユース別では、2027年までに世界全体の年間売上高が49億3,880万ドルに達する病院セグメントで最大のビジネスチャンスが見込まれる。二重特異性mAbsの市場規模は米国で最も大きく、34億8,340万ドルである。 二重特異性mAbs市場の市場トレンドに基づく戦略には、技術的進歩への注力、製品革新、人工知能への注力、標的治療と併用療法への投資、戦略的パートナーシップなどがある。 二重特異性mAbs市場におけるプレーヤー採用戦略には、薬事承認取得による事業強化、戦略的買収による事業能力強化、薬事承認取得による事業強化への注力などが含まれる。 ビジネス・リサーチ・カンパニーは、この機会を活用するために、二重特異性mAbs企業に対し、人工知能への注力、製品イノベーションへの注力、標的治療および併用療法への投資への注力、技術進歩への注力、新興市場での拡大、先進国市場への継続的な注力、研究インセンティブを提供する国での拡大、戦略的パートナーシップへの注力、競争力のある価格での提供、展示会やイベントへの参加、B2Bプロモーションの継続利用、急成長するエンドユーザーへの継続的なターゲット設定、高齢化人口へのターゲット設定を推奨している。 目次1. Executive Summary2. Table Of Contents 3. List Of Figures 4. List Of Tables 5. Report Structure 6. Introduction and Market Characteristics 6.1. General Market Definition 6.2. Summary 6.3. BiSpecific mAbs Market Definition and Segmentations 6.4. Market Segmentation By Type 6.4.1. Catumaxomab (Removab™) 6.4.2. Blinatumomab 6.4.3. Emicizumab 6.4.4. Amivantamab 6.4.5. Faricimab 6.4.6. Teclistamab 6.5. Market Segmentation By Indication 6.5.1. Cancer 6.5.2. Haemophilia A 6.5.3. Ophthalmic 6.6. Market Segmentation By End Use 6.6.1. Hospitals 6.6.2. Research Institutes 6.6.3. Other End-Users 7. Major Market Trends 7.1. Technological Advancements 7.2. Product Innovation 7.3. Focus On Artificial Intelligence 7.4. Investment in Targeted and Combination Therapy 7.5. Strategic Partnerships 8. Global Market Size and Growth 8.1. Market Size 8.2. Historic Market Growth, 2017 – 2022, Value ($ Million) 8.2.1. Market Drivers 2017 – 2022 8.2.2. Market Restraints 2017 – 2022 8.3. Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 8.3.1. Market Drivers 2022 – 2027 8.3.2. Market Restraints 2022 – 2027 9. Global BiSpecific mAbS Market Segmentation 9.1. Global BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 9.2. Global BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 9.3. Global BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 10. BiSpecific mAbS Market, Regional and Country Analysis 10.1. Global BiSpecific mAbS Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 10.2. Global BiSpecific mAbS Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11. Asia-Pacific Market 11.1. Summary 11.2. Market Overview 11.2.1. Region Information 11.2.2. Market Information 11.2.3. Background Information 11.2.4. Government Initiatives 11.2.5. Regulations 11.2.6. Regulatory Bodies 11.2.7. Major Associations 11.2.8. Taxes levied 11.2.9. Corporate Tax Structure 11.2.10. Investments 11.2.11. Major Companies 11.3. Asia-Pacific BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.4. Asia-Pacific BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.5. Asia-Pacific BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.6. Asia-Pacific BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.7. Asia-Pacific BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.8. Asia-Pacific BiSpecific mAbS Market: Country Analysis 11.9. China Market 11.10. Summary 11.11. Market Overview 11.11.1. Country Information 11.11.2. Market Information 11.11.3. Background Information 11.11.4. Government Initiatives 11.11.5. Regulations 11.11.6. Regulatory Bodies 11.11.7. Major Associations 11.11.8. Taxes levied 11.11.9. Corporate tax structure 11.11.10. Investments 11.11.11. Major Companies 11.12. China BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.13. China BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.14. China BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.15. China BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.16. China BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.17. India Market 11.18. India BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.19. India BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.20. India BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.21. India BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.22. India BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.23. Japan Market 11.24. Japan BiSpecific mAbs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.25. Japan BiSpecific mAbs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.26. Japan BiSpecific mAbs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.27. Japan BiSpecific mAbs Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.28. Japan BiSpecific mAbs Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.29. Australia Market 11.30. Australia BiSpecific mAbs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.31. Australia BiSpecific mAbs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.32. Australia BiSpecific mAbs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.33. Australia BiSpecific mAbs Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.34. Australia BiSpecific mAbs Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.35. Indonesia Market 11.36. Indonesia BiSpecific mAbs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.37. Indonesia BiSpecific mAbs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.38. Indonesia BiSpecific mAbs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.39. Indonesia BiSpecific mAbs Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.40. Indonesia BiSpecific mAbs Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.41. South Korea Market 11.42. South Korea BiSpecific mAbs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.43. South Korea BiSpecific mAbs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.44. South Korea BiSpecific mAbs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.45. South Korea BiSpecific mAbs Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.46. South Korea BiSpecific mAbs Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12. Western Europe Market 12.1. Summary 12.2. Market Overview 12.2.1. Region Information 12.2.2. Market Information 12.2.3. Background Information 12.2.4. Government Initiatives 12.2.5. Regulations 12.2.6. Regulatory Bodies 12.2.7. Major Associations 12.2.8. Taxes levied 12.2.9. Corporate tax structure 12.2.10. Investments 12.2.11. Major Companies 12.3. Western Europe BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 12.4. Western Europe BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 12.5. Western Europe BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.6. Western Europe BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.7. Western Europe BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.8. Western Europe BiSpecific mAbS Market: Country Analysis 12.9. UK Market 12.10. UK BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 12.11. UK BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 12.12. UK BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.13. UK BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.14. UK BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.15. Germany Market 12.16. Germany BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 12.17. Germany BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 12.18. Germany BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.19. Germany BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.20. Germany BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.21. France Market 12.22. France BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 12.23. France BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 12.24. France BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.25. France BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.26. France BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 13. Eastern Europe Market 13.1. Summary 13.2. Market Overview 13.2.1. Region Information 13.2.2. Market Information 13.2.3. Background Information 13.2.4. Government Initiatives 13.2.5. Regulations 13.2.6. Regulatory Bodies 13.2.7. Major Associations 13.2.8. Taxes Levied 13.2.9. Corporate Tax Structure 13.2.10. Investments 13.2.11. Major Companies 13.3. Eastern Europe BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 13.4. Eastern Europe BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 13.5. Eastern Europe BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 13.6. Eastern Europe BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 13.7. Eastern Europe BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 13.8. Eastern Europe BiSpecific mAbS Market: Country Analysis 13.9. Russia Market 13.10. Russia BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 13.11. Russia BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 13.12. Russia BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 13.13. Russia BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 13.14. Russia BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 14. North America Market 14.1. Summary 14.2. Market Overview 14.2.1. Region Information 14.2.2. Market Information 14.2.3. Background Information 14.2.4. Government Initiatives 14.2.5. Regulations 14.2.6. Regulatory Bodies 14.2.7. Major Associations 14.2.8. Taxes Levied 14.2.9. Corporate Tax Structure 14.2.10. Investments 14.2.11. Major Companies 14.3. North America BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 14.4. North America BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 14.5. North America BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 14.6. North America BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 14.7. North America BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 14.8. North America BiSpecific mAbS Market: Country Analysis 14.9. USA Market 14.10. Summary 14.11. Market Overview 14.11.1. Country Information 14.11.2. Market Information 14.11.3. Background Information 14.11.4. Government Initiatives 14.11.5. Regulations 14.11.6. Regulatory Bodies 14.11.7. Major Associations 14.11.8. Taxes Levied 14.11.9. Corporate Tax Structure 14.11.10. Investments 14.11.11. Major Companies 14.12. USA BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 14.13. USA BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 14.14. USA BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 14.15. USA BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 14.16. USA BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 15. South America Market 15.1. Summary 15.2. Market Overview 15.2.1. Region Information 15.2.2. Market Information 15.2.3. Background Information 15.2.4. Government Initiatives 15.2.5. Regulations 15.2.6. Regulatory Bodies 15.2.7. Major Associations 15.2.8. Taxes Levied 15.2.9. Corporate Tax Structure 15.2.10. Investments 15.2.11. Major Companies 15.3. South America BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 15.4. South America BiSpecific mAbs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 15.5. South America BiSpecific mAbs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 15.6. South America BiSpecific mAbs Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 15.7. South America BiSpecific mAbs Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 15.8. South America BiSpecific mAbs Market: Country Analysis 15.9. Brazil Market 15.10. Brazil BiSpecific mAbs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 15.11. Brazil BiSpecific mAbs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 15.12. Brazil BiSpecific mAbs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 15.13. Brazil BiSpecific mAbs Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 15.14. Brazil BiSpecific mAbs Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 16. Middle East Market 16.1. Summary 16.2. Market Overview 16.2.1. Region Information 16.2.2. Market Information 16.2.3. Background Information 16.2.4. Government Initiatives 16.2.5. Regulations 16.2.6. Regulatory Bodies 16.2.7. Major Associations 16.2.8. Taxes Levied 16.2.9. Corporate Tax Structure 16.2.10. Investments 16.2.11. Major Companies 16.3. Middle East BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 16.4. Middle East BiSpecific mAbs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 16.5. Middle East BiSpecific mAbs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 16.6. Middle East BiSpecific mAbs Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 16.7. Middle East BiSpecific mAbs Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 17. Africa Market 17.1. Summary 17.2. Market Overview 17.2.1. Region Information 17.2.2. Market Information 17.2.3. Background Information 17.2.4. Government Initiatives 17.2.5. Regulations 17.2.6. Regulatory Bodies 17.2.7. Major Associations 17.2.8. Taxes Levied 17.2.9. Corporate Tax Structure 17.2.10. Investments 17.2.11. Major Companies 17.3. Africa BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 17.4. Africa BiSpecific mAbs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 17.5. Africa BiSpecific mAbs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 17.6. Africa BiSpecific mAbs Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 17.7. Africa BiSpecific mAbs Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 18. Competitive Landscape and Company Profiles 19. Company Profiles 19.1. F. Hoffmann-La Roche AG 19.1.1. Company Overview 19.1.2. Products And Services 19.1.3. Business Strategy 19.1.4. Financial Overview 19.2. Amgen Inc 19.2.1. Company Overview 19.2.2. Products And Services 19.2.3. Business Strategy 19.2.4. Financial Overview 19.3. Johnson & Johnson 19.3.1. Company Overview 19.3.2. Products And Services 19.3.3. Business Strategy 19.3.4. Financial Overview 20. Key Mergers and Acquisitions 20.1. invoX Pharma Acquired F-Star Therapeutics, Inc. 20.2. Amgen Acquired TeneoBio 20.3. Sanofi Acquired Kymab Group Ltd. 20.4. AbCellera Acquired OrthoMab Bispecific Platform 20.5. True North Acquired Stake In Biocon Biologics 21. Opportunities And Strategies 21.1. Global BiSpecific mAbS Market In 2027 – Countries Offering Most New Opportunities 21.2. Global BiSpecific mAbS Market In 2027 – Segments Offering Most New Opportunities 21.3. Global BiSpecific mAbS Market In 2027 – Growth Strategies 21.3.1. Market Trend Based Strategies 21.3.2. Competitor Strategies 22. Bi-Specific mAbs Market, Conclusions And Recommendations 22.1. Conclusions 22.2. Recommendations 22.2.1. Product 22.2.2. Place 22.2.3. Price 22.2.4. Promotion 22.2.5. People 23. Appendix 23.1. Market Data Sources 23.2. Research Methodology 23.3. Currencies 23.4. The Business Research Company 23.5. Copyright and Disclaimer
SummaryBiSpecific mAbS Global Market Opportunities And Strategies To 2032 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global bi-specific mAbS market as it emerges from the COVID-19 shut down. Table of Contents1. Executive Summary2. Table Of Contents 3. List Of Figures 4. List Of Tables 5. Report Structure 6. Introduction and Market Characteristics 6.1. General Market Definition 6.2. Summary 6.3. BiSpecific mAbs Market Definition and Segmentations 6.4. Market Segmentation By Type 6.4.1. Catumaxomab (Removab™) 6.4.2. Blinatumomab 6.4.3. Emicizumab 6.4.4. Amivantamab 6.4.5. Faricimab 6.4.6. Teclistamab 6.5. Market Segmentation By Indication 6.5.1. Cancer 6.5.2. Haemophilia A 6.5.3. Ophthalmic 6.6. Market Segmentation By End Use 6.6.1. Hospitals 6.6.2. Research Institutes 6.6.3. Other End-Users 7. Major Market Trends 7.1. Technological Advancements 7.2. Product Innovation 7.3. Focus On Artificial Intelligence 7.4. Investment in Targeted and Combination Therapy 7.5. Strategic Partnerships 8. Global Market Size and Growth 8.1. Market Size 8.2. Historic Market Growth, 2017 – 2022, Value ($ Million) 8.2.1. Market Drivers 2017 – 2022 8.2.2. Market Restraints 2017 – 2022 8.3. Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 8.3.1. Market Drivers 2022 – 2027 8.3.2. Market Restraints 2022 – 2027 9. Global BiSpecific mAbS Market Segmentation 9.1. Global BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 9.2. Global BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 9.3. Global BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 10. BiSpecific mAbS Market, Regional and Country Analysis 10.1. Global BiSpecific mAbS Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 10.2. Global BiSpecific mAbS Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11. Asia-Pacific Market 11.1. Summary 11.2. Market Overview 11.2.1. Region Information 11.2.2. Market Information 11.2.3. Background Information 11.2.4. Government Initiatives 11.2.5. Regulations 11.2.6. Regulatory Bodies 11.2.7. Major Associations 11.2.8. Taxes levied 11.2.9. Corporate Tax Structure 11.2.10. Investments 11.2.11. Major Companies 11.3. Asia-Pacific BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.4. Asia-Pacific BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.5. Asia-Pacific BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.6. Asia-Pacific BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.7. Asia-Pacific BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.8. Asia-Pacific BiSpecific mAbS Market: Country Analysis 11.9. China Market 11.10. Summary 11.11. Market Overview 11.11.1. Country Information 11.11.2. Market Information 11.11.3. Background Information 11.11.4. Government Initiatives 11.11.5. Regulations 11.11.6. Regulatory Bodies 11.11.7. Major Associations 11.11.8. Taxes levied 11.11.9. Corporate tax structure 11.11.10. Investments 11.11.11. Major Companies 11.12. China BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.13. China BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.14. China BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.15. China BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.16. China BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.17. India Market 11.18. India BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.19. India BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.20. India BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.21. India BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.22. India BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.23. Japan Market 11.24. Japan BiSpecific mAbs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.25. Japan BiSpecific mAbs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.26. Japan BiSpecific mAbs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.27. Japan BiSpecific mAbs Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.28. Japan BiSpecific mAbs Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.29. Australia Market 11.30. Australia BiSpecific mAbs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.31. Australia BiSpecific mAbs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.32. Australia BiSpecific mAbs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.33. Australia BiSpecific mAbs Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.34. Australia BiSpecific mAbs Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.35. Indonesia Market 11.36. Indonesia BiSpecific mAbs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.37. Indonesia BiSpecific mAbs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.38. Indonesia BiSpecific mAbs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.39. Indonesia BiSpecific mAbs Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.40. Indonesia BiSpecific mAbs Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.41. South Korea Market 11.42. South Korea BiSpecific mAbs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.43. South Korea BiSpecific mAbs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.44. South Korea BiSpecific mAbs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.45. South Korea BiSpecific mAbs Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.46. South Korea BiSpecific mAbs Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12. Western Europe Market 12.1. Summary 12.2. Market Overview 12.2.1. Region Information 12.2.2. Market Information 12.2.3. Background Information 12.2.4. Government Initiatives 12.2.5. Regulations 12.2.6. Regulatory Bodies 12.2.7. Major Associations 12.2.8. Taxes levied 12.2.9. Corporate tax structure 12.2.10. Investments 12.2.11. Major Companies 12.3. Western Europe BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 12.4. Western Europe BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 12.5. Western Europe BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.6. Western Europe BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.7. Western Europe BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.8. Western Europe BiSpecific mAbS Market: Country Analysis 12.9. UK Market 12.10. UK BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 12.11. UK BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 12.12. UK BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.13. UK BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.14. UK BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.15. Germany Market 12.16. Germany BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 12.17. Germany BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 12.18. Germany BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.19. Germany BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.20. Germany BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.21. France Market 12.22. France BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 12.23. France BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 12.24. France BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.25. France BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.26. France BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 13. Eastern Europe Market 13.1. Summary 13.2. Market Overview 13.2.1. Region Information 13.2.2. Market Information 13.2.3. Background Information 13.2.4. Government Initiatives 13.2.5. Regulations 13.2.6. Regulatory Bodies 13.2.7. Major Associations 13.2.8. Taxes Levied 13.2.9. Corporate Tax Structure 13.2.10. Investments 13.2.11. Major Companies 13.3. Eastern Europe BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 13.4. Eastern Europe BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 13.5. Eastern Europe BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 13.6. Eastern Europe BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 13.7. Eastern Europe BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 13.8. Eastern Europe BiSpecific mAbS Market: Country Analysis 13.9. Russia Market 13.10. Russia BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 13.11. Russia BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 13.12. Russia BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 13.13. Russia BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 13.14. Russia BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 14. North America Market 14.1. Summary 14.2. Market Overview 14.2.1. Region Information 14.2.2. Market Information 14.2.3. Background Information 14.2.4. Government Initiatives 14.2.5. Regulations 14.2.6. Regulatory Bodies 14.2.7. Major Associations 14.2.8. Taxes Levied 14.2.9. Corporate Tax Structure 14.2.10. Investments 14.2.11. Major Companies 14.3. North America BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 14.4. North America BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 14.5. North America BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 14.6. North America BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 14.7. North America BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 14.8. North America BiSpecific mAbS Market: Country Analysis 14.9. USA Market 14.10. Summary 14.11. Market Overview 14.11.1. Country Information 14.11.2. Market Information 14.11.3. Background Information 14.11.4. Government Initiatives 14.11.5. Regulations 14.11.6. Regulatory Bodies 14.11.7. Major Associations 14.11.8. Taxes Levied 14.11.9. Corporate Tax Structure 14.11.10. Investments 14.11.11. Major Companies 14.12. USA BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 14.13. USA BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 14.14. USA BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 14.15. USA BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 14.16. USA BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 15. South America Market 15.1. Summary 15.2. Market Overview 15.2.1. Region Information 15.2.2. Market Information 15.2.3. Background Information 15.2.4. Government Initiatives 15.2.5. Regulations 15.2.6. Regulatory Bodies 15.2.7. Major Associations 15.2.8. Taxes Levied 15.2.9. Corporate Tax Structure 15.2.10. Investments 15.2.11. Major Companies 15.3. South America BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 15.4. South America BiSpecific mAbs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 15.5. South America BiSpecific mAbs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 15.6. South America BiSpecific mAbs Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 15.7. South America BiSpecific mAbs Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 15.8. South America BiSpecific mAbs Market: Country Analysis 15.9. Brazil Market 15.10. Brazil BiSpecific mAbs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 15.11. Brazil BiSpecific mAbs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 15.12. Brazil BiSpecific mAbs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 15.13. Brazil BiSpecific mAbs Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 15.14. Brazil BiSpecific mAbs Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 16. Middle East Market 16.1. Summary 16.2. Market Overview 16.2.1. Region Information 16.2.2. Market Information 16.2.3. Background Information 16.2.4. Government Initiatives 16.2.5. Regulations 16.2.6. Regulatory Bodies 16.2.7. Major Associations 16.2.8. Taxes Levied 16.2.9. Corporate Tax Structure 16.2.10. Investments 16.2.11. Major Companies 16.3. Middle East BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 16.4. Middle East BiSpecific mAbs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 16.5. Middle East BiSpecific mAbs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 16.6. Middle East BiSpecific mAbs Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 16.7. Middle East BiSpecific mAbs Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 17. Africa Market 17.1. Summary 17.2. Market Overview 17.2.1. Region Information 17.2.2. Market Information 17.2.3. Background Information 17.2.4. Government Initiatives 17.2.5. Regulations 17.2.6. Regulatory Bodies 17.2.7. Major Associations 17.2.8. Taxes Levied 17.2.9. Corporate Tax Structure 17.2.10. Investments 17.2.11. Major Companies 17.3. Africa BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 17.4. Africa BiSpecific mAbs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 17.5. Africa BiSpecific mAbs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 17.6. Africa BiSpecific mAbs Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 17.7. Africa BiSpecific mAbs Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 18. Competitive Landscape and Company Profiles 19. Company Profiles 19.1. F. Hoffmann-La Roche AG 19.1.1. Company Overview 19.1.2. Products And Services 19.1.3. Business Strategy 19.1.4. Financial Overview 19.2. Amgen Inc 19.2.1. Company Overview 19.2.2. Products And Services 19.2.3. Business Strategy 19.2.4. Financial Overview 19.3. Johnson & Johnson 19.3.1. Company Overview 19.3.2. Products And Services 19.3.3. Business Strategy 19.3.4. Financial Overview 20. Key Mergers and Acquisitions 20.1. invoX Pharma Acquired F-Star Therapeutics, Inc. 20.2. Amgen Acquired TeneoBio 20.3. Sanofi Acquired Kymab Group Ltd. 20.4. AbCellera Acquired OrthoMab Bispecific Platform 20.5. True North Acquired Stake In Biocon Biologics 21. Opportunities And Strategies 21.1. Global BiSpecific mAbS Market In 2027 – Countries Offering Most New Opportunities 21.2. Global BiSpecific mAbS Market In 2027 – Segments Offering Most New Opportunities 21.3. Global BiSpecific mAbS Market In 2027 – Growth Strategies 21.3.1. Market Trend Based Strategies 21.3.2. Competitor Strategies 22. Bi-Specific mAbs Market, Conclusions And Recommendations 22.1. Conclusions 22.2. Recommendations 22.2.1. Product 22.2.2. Place 22.2.3. Price 22.2.4. Promotion 22.2.5. People 23. Appendix 23.1. Market Data Sources 23.2. Research Methodology 23.3. Currencies 23.4. The Business Research Company 23.5. Copyright and Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医薬)の最新刊レポート
The Business Research Company (TBRC)社の医薬分野での最新刊レポート
本レポートと同じKEY WORD(hospitals)の最新刊レポート
よくあるご質問The Business Research Company (TBRC)社はどのような調査会社ですか?The Business Research Company (TBRC)はインドを主要拠点に世界の多様な市場を調査・予測し、調査レポートを積極的に出版しています。調査対象には技術、ライフサイエンス、重... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/21 10:26 156.13 円 165.08 円 200.38 円 |